Lupin Limited, a key player in the pharmaceutical sector, is witnessing a positive shift in its share price, which has surged by 2.43% today, hitting approximately ₹2,145.00 during mid-morning trading on December 19, 2024. This uptick comes even as the broader Indian equities have shown signs of decline, making it vital for investors to analyze … Read more
The Food and Drug Administration (FDA) has taken a groundbreaking step by approving Zepbound, a prescription medication developed by Eli Lilly & Co., to treat obstructive sleep apnea (OSA). This decision marks a significant milestone in addressing the health challenges associated with obesity-related sleep disorders. Obstructive sleep apnea is a common condition where individuals experience … Read more
The Food and Drug Administration (FDA) has approved Zepbound, a groundbreaking weight loss drug, as the first prescription medication specifically designed to treat obstructive sleep apnea (OSA). Manufactured by Eli Lilly, Zepbound is authorized for individuals with obesity and moderate to severe OSA. This approval marks a significant milestone in the medical field, offering hope … Read more
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) saw a volatile trading session on Tuesday, initially surging before reversing to trade significantly lower. This came on the heels of a major announcement that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for TNX-102 SL, a 5.6 mg non-opioid treatment. Here’s … Read more
